Medivation actively seeks partnerships for innovative medical technologies—including small-molecule drugs, biotechnology drugs and medical devices—with academic institutions, individuals or other corporations.
A key component of our business strategy is to consider partnering successful programs to pharmaceutical or biotechnology and medical device companies.
We welcome inquiries from biotechnology, pharmaceutical and medical device companies wishing to discuss partnering opportunities with us.
Medivation is actively seeking in-licensing partnerships. We welcome contacts from academic institutions, inventors and biotechnology, pharmaceutical and medical device companies regarding medical technologies that:
- have strong intellectual property positions;
- address significant unmet needs; and
- have the potential to enter clinical development within 12 to 18 months after acquisition.
Chief Financial Officer
525 Market Street
San Francisco, CA 94105
To learn more about our current product pipeline, please click here.